Podcast Episodes

Back to Search
417: Hospitals' next lucrative bet — longevity clinics

Longevity medicine is now estimated to be a multitrillion dollar industry. But what are people paying for, and does it work?

On this week's episode o…

9 hours ago

Short Long
View Episode
416: NIH funding uncertainty thwarts U.S. researchers

How has the National Institutes of Health been spending its budget? Why are biotech investors feeling gloomy? And what is the most quintessential Bos…

1 week, 1 day ago

Short Long
View Episode
415: Mistrust in science and a juicy gene-editing lawsuit

On this week’s episode of "The Readout LOUD": Why have so many Americans lost trust in science? And how have our policy leaders fueled that mistrust?…

2 weeks, 1 day ago

Short Long
View Episode
The FDA's Overton era, and dispatches from Shanghai

"The Readout LOUD" is going international this week.

STAT's Jason Mast joins the podcast from Shanghai, where he's digging into what the rise of Chin…

3 weeks, 1 day ago

Short Long
View Episode
Definium's new psychedelics data, and a reprieve for international scientists

International researchers got a reprieve in the courts this week. But many are still considering leaving the states for opportunities elsewhere. What…

4 weeks, 1 day ago

Short Long
View Episode
Why two promising heart drugs flopped and what's next

On this week’s episode of “The Readout LOUD”: The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treat…

1 month ago

Short Long
View Episode
411: Capricor's data clash and a fugitive in the C-suite

Is the Food and Drug Administration taking inconsistent approaches to Duchenne muscular dystrophy drugs? How will a new batch of drug executives shak…

2 months, 2 weeks ago

Short Long
View Episode
410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing

What does it take to develop a therapy for an ultra-rare disease? What are the allegations against a telehealth company that’s partnered with Novo No…

2 months, 3 weeks ago

Short Long
View Episode
409: Predicting biotech clinical trials & a new Alzheimer's drug controversy

On this week’s episode of "The Readout LOUD": The Kalshi prediction markets are coming for biotech, plus the controversy over an experimental Alzheim…

3 months ago

Short Long
View Episode
408: Whistleblower takes on health insurance and FDA commissioner candidates

Why does getting family health insurance through a job cost as much as buying a new car? How did a whistleblower take on an insurance contractor? And…

3 months, 1 week ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us